ARS-1620 | Covalent Inhibitor of KRAS (Mutant:G12C)
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
KRAS (Mutant:G12C)
  • kobs/[I]:1,100 ± 200 M−1 s−1
  • IC 50:120 nM
Covalent Inhibitor
0.3 - 3.0 uM

Selectivity

In Cell Selectivity Assessment
Selectivity Assessment Description:
Proteome and Transcriptome Profiling the Functional Selectivity of ARS-1620 for KRASG12C and Associa ...

Potency
Cellular
In Vitro

KRAS (Mutant:G12C)

Mode of Action: Covalent Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1016/j.cell.2018.01.006

In Vivo Validations

Mouse
Dose: 50 mg/Kg, 200 mg/Kg
Route of delivery: Oral
Plasma half life: 2.5 h (Mouse), 3.5 h (Human)

DOI Reference: 10.1016/j.cell.2018.01.006

Negative Control Compounds

R-atropisomer

Orthogonal Probes def

SOTORASIB
MRTX-849

Chemical Information

Molecular Formula C21H17ClF2N4O2
SMILEs C=CC(=O)N1CCN(c2ncnc3c(F)c(-c4c(O)cccc4F)c(Cl)cc23)CC1
InChI InChI=1S/C21H17ClF2N4O2/c1-2-16(30)27-6-8-28(9-7-27)21-12-10-13(22)17(19(24)20(12)25-11-26-21)18-14(23)4-3-5-15(18)29/h2-5,10-11,29H,1,6-9H2
Molecular weight 430.10 Da
AlogP 3.768600000000003
HBond acceptors 6
HBond donors 1
Atoms 47

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 15 Feb 2024)
Cellular Use Rating
In Model Organisms
Less potent than later KRAS(G12C) inhibitors
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria